학술논문
P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemia
Document Type
Article
Author
Lin, K.H.; Rutter, J.C.; Xie, A.; Killarney, S.T.; Bassil, C.F.; Hoj, J.; Washart, R.; Ang, H.X.; Cerda-Smith, C.; Lu, M.; Wood, K.C.; Vaganay, C.; Benaksas, C.; Ling, F.; Sodaro, G.; Meslin, P.-A.; Fenouille, N.; Forget, A.; Itzykson, R.; Benajiba, L.; Puissant, A.; Chaintreuil, P.; Jacquel, A.; Auberger, P.; Lin, J.; Sheng, Z.; Owzar, K.; Pierobon, M.; Petricoin, E.; Li, X.; Chilkoti, A.; Rizzieri, D.A.; Pardee, T.S.
Source
In: Nature Cancer . (Nature Cancer, July 2022, 3(7):837-851)
Subject
Language
English
ISSN
26621347